Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 246 participants.

Also called NCT01191450

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 246 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01191450
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Brazil (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01191450. Randomized; no masking; primary purpose treatment. Start 2011-08 (registry gives no type); primary completion 2013-08 (actual). Results posted on 2025-06-12.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension
Acronym
CARD
Condition
Arterial Hypertension
Intervention (Drug)
Chlorthalidone 25 mg + amiloride hydrochloride 5 mg
Intervention (Drug)
Higroton® Laboratório Novartis
Lead sponsor
Eurofarma Laboratorios S.A. (class: industry)

Record details

Record id
cardio:ct-nct01191450
Content hash
29432e161158868af516cc64771f4cf38149e747c7754822027b068274e6fe88